{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}]}],"denomUnitsSelected":"sentinel lymph nodes (SLNs)","denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"17"}],"units":"sentinel lymph nodes (SLNs)"}],"description":"The number of SLN detected by contrast enhanced ultrasound will be compared to the number of SLN detected by the standard of care (i.e., by blue dye or by PET-CT).","groups":[{"description":"Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment.\n\nPerflubutane Microbubble: Given subdermally\n\nContrast-Enhanced Ultrasound: Undergo ultrasound","id":"OG000","title":"Diagnostic (Perflubutane Microbubble, Ultrasound)"}],"paramType":"NUMBER","populationDescription":"Only participants who completed CEUS and surgery (N=5) were analyzed.","reportingStatus":"POSTED","timeFrame":"up to 30 minutes during CEUS procedure","title":"Number of Sentinel Lymph Nodes (SLNs) Identified by Lymphosonography as Well as Blue Dye or Positron Emission Tomography (PET)-Computed Tomography (CT)","type":"PRIMARY","typeUnitsAnalyzed":"sentinel lymph nodes (SLNs)","unitOfMeasure":"sentinel lymph nodes (SLNs)"}